HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
HARP
Delisted
HARP was delisted on the 8th of March, 2024.
49 hedge funds and large institutions have $13.7M invested in Harpoon Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 16
Holders
49
Holding in Top 10
1
Calls
$29K
Puts
$7K
Top Buyers
| 1 | +$403K | |
| 2 | +$239K | |
| 3 | +$67K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$50.4K |
| 5 |
SFA
Sequoia Financial Advisors
Akron,
Ohio
|
+$43.5K |
Top Sellers
| 1 | -$1.1M | |
| 2 | -$769K | |
| 3 | -$563K | |
| 4 |
BlackRock
New York
|
-$242K |
| 5 |
Renaissance Technologies
New York
|
-$108K |